Drug Shortage Report for DOCETAXEL INJECTION
Report ID | 1680 |
Drug Identification Number | 02412225 |
Brand name | DOCETAXEL INJECTION |
Common or Proper name | DOCETAXEL |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DOCETAXEL |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 0.72ML |
ATC code | L01CD |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-02-29 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 2 of 2